A new study is raising concerns that doxy PEP, a strategy of taking medication to prevent STIs, might already be contributing to the rise of antibiotic-resistant bacteria.| American Sexual Health Association
A clinical trial of a new antibiotic found that it works just as well as a current drug regimen for treating gonorrhea infections. This is important because the bacteria that causes gonorrhea has become resistant to most existing antibiotics.| American Sexual Health Association
New data on STIs from CDC reveals 2.5 million cases of chlamydia, gonorrhea, and syphilis were reported in the US in 2022, with rates of syphilis have up an alarming 80% since 2018.| American Sexual Health Association
